![Alan Rubino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alan Rubino
Direttore/Membro del Consiglio presso
VERICEL CORPORATION
Patrimonio netto: 2 M $ in data 31/05/2026
Profilo
Alan L.
Rubino was the founder of Akrimax Pharmaceuticals LLC, founded in 2007, where the title held was President & Chief Executive Officer from 2008 to 2010.
Mr. Rubino was the founder of New American Therapeutics, Inc., founded in 2010, where the title held was President & Chief Executive Officer from 2010 to 2012.
Current jobs include Chairman at AMO Pharma Ltd. since 2021, Independent Director at Vericel Corp.
since 2005, Director at HealthCare Institute of New Jersey, and Director at Genisphere LLC since 2010.
Former jobs include President, Chief Executive Officer & Director at Emisphere Technologies, Inc. from 2012 to 2019; Chairman, President & Chief Executive Officer at RenovaCare, Inc. from 2020 to 2021; Director at BioNJ, Inc. in 2014; Independent Director at SANUWAVE Health, Inc. from 2003 to 2021; Director at Rutgers Business School; Senior Executive Officer at Genentech, Inc.; President & Chief Operating Officer at W World Corp.
from 2005 to 2007; Executive Vice President & General Manager at Interpace Biosciences, Inc. in 2005; Senior Executive Officer at Hoffmann-La Roche Ltd. Education includes an undergraduate degree from Rutgers State University of New Jersey, conferred in 1976.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VERICEL CORPORATION 0,13% | 29/04/2026 | 64.194 ( 0,13% ) | 2 M $ | 31/05/2026 |
Posizioni attive di Alan Rubino
| Società | Posizione | Inizio |
|---|---|---|
| VERICEL CORPORATION | Direttore/Membro del Consiglio | 28/09/2005 |
Genisphere LLC
 Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins | Direttore/Membro del Consiglio | 01/05/2010 |
HealthCare Institute of New Jersey
 HealthCare Institute of New Jersey The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024. | Direttore/Membro del Consiglio | - |
AMO Pharma Ltd.
 AMO Pharma Ltd. BiotechnologyHealth Technology Operates as an biopharmaceutical company that develops new treatments for serious and debilitating diseases | Presidente | 16/08/2021 |
Precedenti posizioni note di Alan Rubino
| Società | Posizione | Fine |
|---|---|---|
| SANUWAVE HEALTH, INC. | Direttore/Membro del Consiglio | 03/06/2021 |
| RENOVACARE, INC. | Amministratore Delegato | 25/03/2021 |
| EMISPHERE TECHNOLOGIES, INC. | Amministratore Delegato | 15/10/2019 |
New American Therapeutics, Inc.
 New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Amministratore Delegato | 01/07/2012 |
Akrimax Pharmaceuticals LLC
 Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Amministratore Delegato | 01/09/2010 |
Formazione di Alan Rubino
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
69
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
W World Corp.
 W World Corp. Pharmaceuticals: MajorHealth Technology Develops specialty pharmaceutical products | Health Technology |
Vericel Corp.
 Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Interpace Biosciences, Inc.
 Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
RenovaCare, Inc.
 RenovaCare, Inc. Medical SpecialtiesHealth Technology Develops autologous stem cell therapies | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HealthCare Institute of New Jersey
HealthCare Institute of New Jersey The private company is based in Bridgewater, NJ. The HealthCare Institute of New Jersey (HINJ) is a trade association representing research-based biopharmaceutical and medical technology companies. It advocates for policies that expand patient access to medicines, medical devices, vaccines, and diagnostics, and promotes value-based healthcare and fair drug pricing. HINJ supports legislation on antimicrobial resistance and diagnostic regulation modernization, monitors policy to foster a competitive life sciences ecosystem, and emphasizes corporate social responsibility, including philanthropy, community engagement, environmental sustainability, and employee volunteerism. The organization advances diversity, equity, and inclusion initiatives, collaborates with government, academia, and industry partners, and administers patient assistance programs such as the Rx4NJ partnership and promotes awareness of NJSAVE. Christine Buteas has been the CEO of the company since 2024. | |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services Promotes the biotechnology industry in New Jersey | Commercial Services |
Genisphere LLC
Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins | Electronic Technology |
SANUWAVE Health, Inc.
 SANUWAVE Health, Inc. Medical SpecialtiesHealth Technology Operates as a shockwave technology company using noninvasive, high energy, acoustic shockwaves for regenerative medicine and other applications | Health Technology |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Health Technology |
Rutgers Business School
 Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AMO Pharma Ltd.
AMO Pharma Ltd. BiotechnologyHealth Technology Operates as an biopharmaceutical company that develops new treatments for serious and debilitating diseases | Health Technology |
Hoffmann-La Roche Ltd.
 Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
